
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant
Patients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vaccines for protection against SARS-CoV-2 three months post-transplant, according to a large, prospective, observational study led collaboratively […]